Prospective Analysis of the Impact of Commercialized Hybrid Closed-Loop System on Glycemic Control, Glycemic Variability, and Patient-Related Outcomes in Children and Adults: A Focus on Superiority Over Predictive Low-Glucose Suspend Technology. Diabetes Technol Ther. 2020 Dec;22(12):912-919. doi: 10.1089/dia.2019.0400. Epub 2020 Aug 28.PMID: 31855446.F.I.:4.403

Inicio Repositorio Prospective Analysis of the Impact of Commercialized Hybrid Closed-Loop System on Glycemic Control, Glycemic Variability, and Patient-Related Outcomes in Children and Adults: A Focus on Superiority Over Predictive Low-Glucose Suspend Technology. Diabetes Technol Ther. 2020 Dec;22(12):912-919. doi: 10.1089/dia.2019.0400. Epub 2020 Aug 28.PMID: 31855446.F.I.:4.403

2020/12

Autores/as:

Beato-Víbora PI, Gallego-Gamero F, Lázaro-Martín L, Romero-Pérez MDM, Arroyo-Díez FJ.

Servicio:

Endocrinología y Nurición.- . Hospital Universitario de Badajoz

Tipo:

Artículo

Materia:

{«label»:»Resumen Pubmed»,»link»:»https://pubmed.ncbi.nlm.nih.gov/31855446/»}

info@areasaludbadajoz.com

Contacto

Salud

Información

Ciudadanos

info@areasaludbadajoz.com

Contacto

Salud​

Información​

Ciudadanos​

Salud

Información

Ciudadanos